Michael H. Bachmann

Helmholtz-Zentrum Dresden-Rossendorf — Germany

Medicine · Health Sciences

37h-index6.8kcitations98works0.42yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

CAR-T cell therapy research(16), Immunotherapy and Immune Responses(10), Virus-based gene therapy research(10), RNA Interference and Gene Delivery(10), Extracellular vesicles in disease(10)

Publications98 total

The influences of charge on the pharmacokinetic behaviour of copper-based radioimmunoconjugates
Nuclear Medicine and Biology·2025
Design of novel FAPI Target Modules for simultaneous diagnostic imaging, endoradiotherapy, and UniCAR T-cell immunotherapy
Nuclear Medicine and Biology·2025
Design of innovative FAP-target modules for simultaneous delivery of CAR-T cell-and radiotherapy
Nuclear Medicine and Biology·2025Open Access
Extended Gate FET Biosensor for Rapid Monitoring of Living Drugs
2025
Label‐Free FET Based Biosensor for Detection of Engineered CAR T‐Cells at Single Cell Resolution
Advanced Sensor Research·2025Open Access
Exploring Morphology of Thermoplasmonic Nanoparticles to Synergize Immunotherapeutic Fibroblast Activation Protein‐Positive Cell Sensitization and Photothermal Therapy
Small Science·2025· 1 citedOpen Access
3D Microphysiological Tumor Model for Dual-Targeting CAR T Cell Immunotherapy
2024· 2 citedOpen Access
Towards Precision CAR T-cell Immunotherapy: extended gate FET biosensor for personalized drug monitoring
2024· 1 citedOpen Access
Impact of Viscosity on Human Hepatoma Spheroids in Soft Core–Shell Microcapsules (Adv. Healthcare Mater. 11/2024)
Advanced Healthcare Materials·2024Open Access
Molecular imaging of bacterial outer membrane vesicles based on bacterial surface display
Scientific Reports·2023· 14 citedOpen Access
Data from Microvesicle-Mediated Delivery of Minicircle DNA Results in Effective Gene-Directed Enzyme Prodrug Cancer Therapy
2023Open Access
Supplementary Data from Microvesicle-Mediated Delivery of Minicircle DNA Results in Effective Gene-Directed Enzyme Prodrug Cancer Therapy
2023Open Access
Data from Microvesicle-Mediated Delivery of Minicircle DNA Results in Effective Gene-Directed Enzyme Prodrug Cancer Therapy
2023Open Access
Supplementary Data from Microvesicle-Mediated Delivery of Minicircle DNA Results in Effective Gene-Directed Enzyme Prodrug Cancer Therapy
2023Open Access
Data from CNOB/ChrR6, a new prodrug enzyme cancer chemotherapy
2023Open Access
Supplementary Fig. from CNOB/ChrR6, a new prodrug enzyme cancer chemotherapy
2023Open Access
Data from CNOB/ChrR6, a new prodrug enzyme cancer chemotherapy
2023Open Access
Supplementary Fig. from CNOB/ChrR6, a new prodrug enzyme cancer chemotherapy
2023Open Access
Supplementary Methods, Figures 1-7 from Longitudinal, Noninvasive Imaging of T-Cell Effector Function and Proliferation in Living Subjects
2023Open Access
Supplementary Methods, Figures 1-7 from Longitudinal, Noninvasive Imaging of T-Cell Effector Function and Proliferation in Living Subjects
2023Open Access
page 1 of 5Next →

Frequent Co-authors

Christopher H. Contag(21), Robert S. Negrin(6), Sanjiv S. Gambhir(5), Masamitsu Kanada(4), Yu-An Cao(4), Jonathan Hardy(3), Matthias Edinger(3), C. Garrison Fathman(3), Cheryl Koopman(3), David Spiegel(3), James I. Mullins(3), William J. Maloney(3), Bonnie L. King(3), Vici Varghese(3), W. Jeffrey Fessel(3), Robert W. Shafer(3), Caitlin E. O'Connell‐Rodwell(3), A. Matin(2), Manishkumar Patel(2), Ya-Fang Chang(2)